💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

BioNote Inc (377740)

Seoul
Currency in KRW
Disclaimer
4,620.00
+40.00(+0.87%)
Closed
377740 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
High dividend Yield
Fair Value
Day's Range
4,565.004,665.00
52 wk Range
3,800.006,400.00
Bid/Ask
4,620.00 / 4,645.00
Prev. Close
4,580
Open
4,575
Day's Range
4,565-4,665
52 wk Range
3,800-6,400
Volume
140,943
Average Vol. (3m)
671,594
1-Year Change
-7.73%
Fair Value
Unlock
Fair Value Upside
Unlock
377740 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low Price / Book multiple

BioNote Inc Company Profile

BioNote, Inc., manufactures and sells in-vitro diagnostic animal medicines in South Korea. It offers animal diagnostics products, such as fluorescence immunoassay, molecular diagnostics, clinical biochemistry, rapid immunoassay, and enzyme-linked immunosorbent assay products. The company also provides bio-content products, including rapid immunoassay for humans, human intermediate goods, and bio-contents reagents. In addition, it engages in the production and sell of medical devices. BioNote, Inc. was founded in 2003 and is headquartered in Hwaseong-si, South Korea.

Compare 377740 to Peers and Sector

Metrics to compare
377740
Peers
Sector
Relationship
P/E Ratio
5.8x−4.8x−0.6x
PEG Ratio
0.030.010.00
Price / Book
0.3x2.0x2.6x
Price / LTM Sales
5.0x4.8x3.1x
Upside (Analyst Target)
-26.3%55.0%
Fair Value Upside
Unlock16.1%6.8%Unlock

FAQ

What Is the BioNote (377740) Stock Price Today?

The BioNote stock price today is 4,620.00

What Stock Exchange Does BioNote Trade On?

BioNote is listed and trades on the Seoul stock exchange.

What Is the Stock Symbol for BioNote?

The stock symbol for BioNote is "377740."

Does BioNote Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 4.33%.

What Is the BioNote Market Cap?

As of today, BioNote market cap is 471.50B.

What is BioNote Earnings Per Share?

The BioNote EPS is 800.17.

What Is the Next BioNote Earnings Date?

BioNote will release its next earnings report on Nov 12, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.